Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Groups

Publications

  • Cameselle-Teijeiro JM; Bella Cueto MR; Eloy C; Abdulkader I; Amendoeira I; Matías-Guiu X; Sobrinho-Simões M

    Tumores de la glándula tiroides. Propuesta para el manejo y estudio de las muestras de pacientes con neoplasias tiroideas.

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 53 27-36. .

    [doi:10.1016/j.patol.2019.03.003]

  • Davidson, B; Matias-Guiu, X; Lax, SF

    The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma.

    VIRCHOWS ARCHIV 476 489-490. .

    [doi:10.1007/s00428-020-02762-3]

  • Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A

    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .

    [doi:10.1016/j.jid.2019.11.014]

  • Etxeberria, I; Bolaños E; Quetglas, JI; Gros, A; Villanueva, A; Palomero, J; Sanchez-Paulete, AR; Piulats, JM; Matias-Guiu, X; Olivera, I; Ochoa, MC; Labiano, S; Garasa, S; Rodriguez, I; Vidal, A; Mancheño U; Hervas-Stubbs, S; Azpilikueta, A; Otano, I; Aznar, MA; Sanmamed, MF; Inoges, S; Berraondo, P; Teijeira, A; Melero, I

    Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8(+)T Cells

    CANCER CELL 36 613-629. .

    [doi:10.1016/j.ccell.2019.10.006]

  • Capdevila, J; Mayor, R; Mancuso, FM; Iglesias, C; Caratu, G; Matos, I; Zafon, C; Hernando, J; Petit, A; Nuciforo, P; Cameselle-Teijeiro, JM; Alvarez, CV; Recio, JA; Tabernero, J; Matias-Guiu, X; Vivancos, A; Seoane, J

    Early evolutionary divergence between papillary and anaplastic thyroid cancers (vol 29, pg 1454, 2018)

    ANNALS OF ONCOLOGY 30 1843-1843. .

    [doi:10.1093/annonc/mdz216]

  • Roman-Canal, B; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Gonzalez, E; Ojanguren, A; Recuero, JL; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Porcel, JM; Matias-Guiu, X; Colas, E

    EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer

    SCIENTIFIC REPORTS 9 15057-15057. .

    [doi:10.1038/s41598-019-51578-y]

  • Palacios, Jose; Matias-Guiu, Xavier; Rodriguez-Peralto, Jose Luis; de Alava, Enrique; Lopez, Jose Ignacio

    Retos e implicaciones clínicas de la heterogeneidad intratumoral

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 52 234-241. .

    [doi:10.1016/j.patol.2019.04.004]

  • Majem, B; Parrilla, A; Jimenez, C; Suarez-Cabrera, L; Barber, M; Marin, A; Castellvi, J; Tamayo, G; Moreno-Bueno, G; Ponce, J; Matias-Guiu, X; Alameda, F; Romero, I; Sanchez, JL; Perez-Benavente, A; Moran, S; Esteller, M; Reventos, J; Rigau, M; Gil-Moreno, A; Segura, MF; Santamaria, A

    MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways

    ONCOGENE 38 6035-6050. .

    [doi:10.1038/s41388-019-0860-0]

  • Visser NCM; van der Putten LJM; van Egerschot, A; Van de Vijver, KK; Santacana, M; Bronsert, P; Hirschfeld, M; Colas, E; Gil-Moreno, A; Garcia, A; Mancebo, G; Alameda, F; Krakstad, C; Tangen, IL; Huvila, J; Schrauwen, S; Koskas, M; Walker, F; Weinberger, V; Minar, L; Hausnerova, J; Snijders MPLM; van den Berg-van Erp, S; Matias-Guiu, X; Trovik, J; Amant, F; Massuger LFAG; Bulten, J; Pijnenborg JMA

    Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study

    HUMAN PATHOLOGY 89 90-98. .

    [doi:10.1016/j.humpath.2019.04.014]

  • Baena Fustegueras JA; Gonzalez, FH; Caldero, SG; de la Fuente Juárez MC; Lopez, SR; Riu, FR; Petit, NM; Alvarez, PM; Torello, AL; Matias-Guiu, X; Olsina Kissler JJ

    Magnetic detection of sentinel lymph node in papillary thyroid carcinoma: The MAGIC-PAT study results

    EJSO 45 1175-1181. .

    [doi:10.1016/j.ejso.2019.03.017]

  • Leskela, S; Perez-Mies, B; Rosa-Rosa, JM; Cristobal, E; Biscuola, M; Palacios-Berraquero, ML; Ong, S; Matias-Guiu Guia X; Palacios, J

    Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma

    Cancers 11 -. .

    [doi:10.3390/cancers11070964]

  • Roman-Canal, B; Tarragona, J; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Sierra, JE; Rufas, M; Gonzalez, E; Porcel, JM; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Matias-Guiu, X; Colas, E

    EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer

    Journal Of Translational Medicine 17 208-208. .

    [doi:10.1186/s12967-019-1954-8]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment